CRISPR Telomere Extension via DNA Tail Replacement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for extending telomeres to promote longer and healthier lives are limited by requiring significant lifestyle changes, lack of guarantee for success, and the need for repeated interventions, which can have unforeseen consequences such as promoting cancerous cell growth.
Innovation Solution
A novel gene editing process using CRISPR that directly extends telomeres by replacing the tail of the DNA strand with a new, longer telomere sequence, allowing for precise control over telomere length and avoiding manipulation of telomerase or other cellular functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If CRISPR gene editing is used to extend telomeres, then telomere length is increased and health span is extended, but there is a risk of promoting cancerous cell growth
Solution Approach 1:
The patent applies local quality by making the CRISPR system selectively active only in healthy cells. The guide RNA is designed to match only healthy cell DNA sequences, ensuring that telomere extension occurs locally in healthy cells while cancerous cells with mutated sequences are excluded from the effect, thus preventing their proliferation.
Solution Approach 2:
The patent implements feedback mechanisms through multiple safety checks: (1) The guide RNA sequence is designed to bind only to healthy cell DNA, providing molecular-level feedback discrimination; (2) The system includes monitoring capabilities to detect and stop the process if cancerous cell activation is detected; (3) Telomere length is monitored to prevent excessive extension that could indicate cancerous transformation.
2Duration of action of stationary object
If lifestyle changes are implemented to extend telomeres, then health span may be improved, but significant and continual effort is required with no guarantee of success
Solution Approach 1:
The patent replaces the mechanical system of lifestyle modifications (diet, exercise, stress management) with a molecular-level genetic editing system. Instead of requiring continual behavioral changes, a single CRISPR gene editing intervention directly modifies the DNA to extend telomeres, substituting complex behavioral mechanics with precise molecular mechanics.
Solution Approach 2:
The patent applies preliminary action by performing the telomere extension through a single upfront gene editing intervention rather than requiring continual lifestyle maintenance. The CRISPR edit is made once to the DNA sequence, and the effect persists without requiring repeated actions or continual effort from the patient.
3Duration of action of stationary object
If repeated interventions are used to extend telomeres, then telomere length may be increased, but the frequency of interventions increases the risk of adverse effects
Solution Approach 1:
The patent uses preliminary action by designing the CRISPR system to achieve the desired telomere extension effect in a single intervention rather than requiring repeated treatments. The guide RNA and Cas9 complex are delivered once to make the genetic edit, and the extended telomeres persist through subsequent cell divisions without needing reinforcement.
Solution Approach 2:
The patent employs disposable single-use CRISPR components that are delivered in one intervention. The guide RNA and Cas9 proteins are designed as single-use agents that perform their function and are then degraded, eliminating the need for repeated administrations and reducing cumulative exposure to potential adverse effects from multiple interventions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables significant telomere growth with a single application, providing precise control over telomere length, reducing the risk of adverse effects, and avoiding the need for frequent interventions, while ensuring that cancerous or damaged cells are not inadvertently extended.
Implementation Method 1
A novel gene editing process using CRISPR that directly extends telomeres by replacing the tail of the DNA strand with a new, longer telomere sequence
Data Source
AI summary
The present invention concerns a method for extending telomeres that have decayed in length without engaging bodily functions such as telomerase, so as to prevent cells from reaching the Hayflick limit and thus avoid risk of becoming senescent. This process is intended to improve the body's ability to restore damaged self-repair mechanisms, cells, and tissues at a pace that is no longer outmatched by senescent cell accumulation, thus reducing probability of age-related maladies including illness, infirmity, disease, and cognitive decline. The present invention also concerns a corresponding regimen of additional procedures and techniques to restore cellular functionality and thus bodily health such as: introducing artificially produced stem cells and/or converting bodily cells to stem cells; doing so in a manner that prevents detection by the body's own immune system; removing senescent cells (“Senolytics”); and replenishing necessary materials extracted during the senolytic process such as P53, all as part of a collective strategy for improving health, health span, and longevity.